Physiol. Genomics AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Physiol. Genomics (September 27, 2005). doi:10.1152/physiolgenomics.00069.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/3/343    most recent
00069.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dhahbi, J. M
Right arrow Articles by Spindler, S. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dhahbi, J. M
Right arrow Articles by Spindler, S. R
Submitted on March 22, 2005
Accepted on September 7, 2005

Identification of potential caloric restriction mimetics by microarray profiling

Joseph M Dhahbi1, Patricia L Mote2, Gregory M Fahy3, and Stephen R Spindler2*

1 BioMarker Pharmaceuticals, Inc., Alameda, CA, USA
2 Biochemistry, University of California, Riverside, Riverside, CA, USA
3 Intervene Biomedical, Norco, CA, USA

* To whom correspondence should be addressed. E-mail: spindler{at}ucr.edu.

To facilitate the development of assays for the discovery of pharmaceuticals capable of mimicking the effects of caloric restriction on life- and healthspan (CR mimetics), we evaluated the effectiveness of glucoregulatory and putative cancer chemopreventatives in reproducing the hepatic gene-expression profile produced by long-term CR (LTCR) using Affymetrix microarrays. We have shown that CR initiated late in life begins to extend lifespan, reduce cancer as a cause of death, and reproduce ~three quarters of the genomic effects of LTCR in 8 weeks (CR8). Eight weeks of metformin treatment was superior to CR8 at reproducing LTCR-like gene expression changes, maintaining a superior number of such changes over a broad range of statistical stringencies, and producing more gene ontology terms overlapping those produced by LTCR. Consistent with these results, metformin has been shown to reduce cancer incidence in mice and humans. Phenformin, a chemical cousin of metformin, extends lifespan and reduces tumor incidence in mice. Taken together, these results indicate that gene-expression biomarkers can be used to identify promising candidate CR mimetics.




This article has been cited by other articles:


Home page
 Cancer Prevention ResearchHome page
J. R. Fay, V. Steele, and J. A. Crowell
Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase
Cancer Prevention Research, April 1, 2009; 2(4): 301 - 309.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, A. Lopez-Bermejo, M. Diaz, M. V. Marcos, and F. de Zegher
Metformin Treatment for Four Years to Reduce Total and Visceral Fat in Low Birth Weight Girls with Precocious Pubarche
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1841 - 1845.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
R. J. Colman, G. Nam, L. Huchthausen, J. D. Mulligan, and K. W. Saupe
Energy Restriction-Induced Changes in Body Composition Are Age Specific in Mice
J. Nutr., October 1, 2007; 137(10): 2247 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. Fontana and S. Klein
Aging, Adiposity, and Calorie Restriction
JAMA, March 7, 2007; 297(9): 986 - 994.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
M. Liang and B. Ventura
Physiological genomics in PG and beyond: October to December 2005
Physiol Genomics, December 14, 2005; 24(1): 1 - 3.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.